Literature DB >> 29322501

Response to "Antiretroviral Therapy With Efavirenz in HIV-Infected Pregnant Women: Understanding the Possible Mechanisms for Drug-Drug Interaction".

Prasanna Jagannathan1, Richard Kajubi2,3, Francesca T Aweeka4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29322501      PMCID： PMC5847448          DOI： 10.1002/cpt.963

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

1.  Is there a differential conversion of artesunate to dihydroartemisinin in pregnant vs. post-partum patients with malaria after oral artesunate dosing?

Authors:  Nuggehally R Srinivas
Journal:  Br J Clin Pharmacol       Date:  2015-12-01       Impact factor: 4.335

2.  Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria Chemoprevention.

Authors:  R Kajubi; L Huang; P Jagannathan; N Chamankhah; M Were; T Ruel; C A Koss; A Kakuru; N Mwebaza; M Kamya; D Havlir; G Dorsey; P J Rosenthal; F T Aweeka
Journal:  Clin Pharmacol Ther       Date:  2017-05-30       Impact factor: 6.875

3.  Impact of efavirenz on intestinal metabolism and transport: insights from an interaction study with ezetimibe in healthy volunteers.

Authors:  S Oswald; H E Meyer zu Schwabedissen; A Nassif; C Modess; Z Desta; E T Ogburn; J Mostertz; M Keiser; J Jia; A Hubeny; A Ulrich; D Runge; M Marinova; D Lütjohann; H K Kroemer; W Siegmund
Journal:  Clin Pharmacol Ther       Date:  2012-02-01       Impact factor: 6.875

4.  Safety, tolerability, and pharmacokinetic interactions of the antituberculous agent TMC207 (bedaquiline) with efavirenz in healthy volunteers: AIDS Clinical Trials Group Study A5267.

Authors:  Kelly E Dooley; Jeong-Gun Park; Susan Swindells; Reena Allen; David W Haas; Yoninah Cramer; Francesca Aweeka; Ilene Wiggins; Amita Gupta; Patricia Lizak; Sonia Qasba; Rolf van Heeswijk; Charles Flexner
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-15       Impact factor: 3.731

5.  Compartment-specific gene regulation of the CAR inducer efavirenz in vivo.

Authors:  H E Meyer zu Schwabedissen; S Oswald; C Bresser; A Nassif; C Modess; Z Desta; E T Ogburn; M Marinova; D Lütjohann; C Spielhagen; M Nauck; H K Kroemer; W Siegmund
Journal:  Clin Pharmacol Ther       Date:  2012-05-16       Impact factor: 6.875
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.